Cell Therapy Catapult now eligible as partner in Biomedical Catalyst projects

Round 4 now open for applications

Round 4 of the Technology Strategy Board/Medical Research Council Biomedical Catalyst programme is now open for Early and Late Stage Award Applications.

Under changes to the programme guidance, research organisations such as the Cell Therapy Catapult are now eligible to partner with companies in applications. Previously, companies could only partner with academics. More details on the scheme and updated guidance can be found here.

For more register for more information about the Cell Therapy Catapult or to make a project enquiry please contact us here.